Vital Innovations Schedules 26 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Consider Dividend

Bulletin Express

08/14

Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include:

• Approval of the consolidated interim results for the six months ended 30 June 2026. • Deliberation on the declaration and amount of an interim dividend, if any.

The meeting will be chaired by Ms. Rong Xiuli. As of 14 August 2026, the board comprises four executive directors—Ms. Rong Xiuli, Mr. Rong Shengli, Mr. Yin Xuquan and Mr. Wong Ho Chun—and three independent non-executive directors—Mr. Han Xiaojing, Mr. Wong Pong Chun James and Mr. Leung Man Fai.

The company is incorporated in the Cayman Islands and its shares trade on the Stock Exchange of Hong Kong under stock code 06133.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1184550663"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184550663\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184550663?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 17:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184550663","market":"us","top_or_hot":-1,"title":"Vital Innovations Schedules 26 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Consider Dividend","media":"Bulletin Express","content":"<p>Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include:</p>\n<p>• Approval of the consolidated interim results for the six months ended 30 June 2026.  \n• Deliberation on the declaration and amount of an interim dividend, if any.</p>\n<p>The meeting will be chaired by Ms. Rong Xiuli. As of 14 August 2026, the board comprises four executive directors—Ms. Rong Xiuli, Mr. Rong Shengli, Mr. Yin Xuquan and Mr. Wong Ho Chun—and three independent non-executive directors—Mr. Han Xiaojing, Mr. Wong Pong Chun James and Mr. Leung Man Fai.</p>\n<p>The company is incorporated in the Cayman Islands and its shares trade on the Stock Exchange of Hong Kong under stock code 06133.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vital Innovations Schedules 26 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Consider Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVital Innovations Schedules 26 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Consider Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 17:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include:</p>\n<p>• Approval of the consolidated interim results for the six months ended 30 June 2026.  \n• Deliberation on the declaration and amount of an interim dividend, if any.</p>\n<p>The meeting will be chaired by Ms. Rong Xiuli. As of 14 August 2026, the board comprises four executive directors—Ms. Rong Xiuli, Mr. Rong Shengli, Mr. Yin Xuquan and Mr. Wong Ho Chun—and three independent non-executive directors—Mr. Han Xiaojing, Mr. Wong Pong Chun James and Mr. Leung Man Fai.</p>\n<p>The company is incorporated in the Cayman Islands and its shares trade on the Stock Exchange of Hong Kong under stock code 06133.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06133","symbol_name":"维太创科","start_time":0,"source_url":"","article_id":"1184550663","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184550663","pubTimestamp":1786699659,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include: • Approval of the consolidated interim results for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06133":"维太创科"},"translate_title":"Vital Innovations 计划于 2026 年 8 月 26 日召开董事会会议，批准 26 年上半年中期业绩并考虑股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06133":1},"content_text":"Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include:\n• Approval of the consolidated interim results for the six months ended 30 June 2026.  \n• Deliberation on the declaration and amount of an interim dividend, if any.\nThe meeting will be chaired by Ms. Rong Xiuli. As of 14 August 2026, the board comprises four executive directors—Ms. Rong Xiuli, Mr. Rong Shengli, Mr. Yin Xuquan and Mr. Wong Ho Chun—and three independent non-executive directors—Mr. Han Xiaojing, Mr. Wong Pong Chun James and Mr. Leung Man Fai.\nThe company is incorporated in the Cayman Islands and its shares trade on the Stock Exchange of Hong Kong under stock code 06133.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}